Omar
@Omar__Azem
Followers
125
Following
245
Media
1
Statuses
40
Neomed ‘21 | PGY-4 | #RadOnc @ Rush University Medical Center ☢️
Cleveland, OH
Joined September 2018
If a mucosal melanoma ever sneaks onto your patient list, we’ve got you covered🫡 Check out our review on Radiation Therapy in the Management of HNMM https://t.co/WnUqZfeV3I
#mdpicancers via @Cancers_MDPI @DrNikhilJoshiMD @MikeJelinekMD
mdpi.com
Mucosal melanoma of the head and neck (HNMM) is a rare but highly aggressive malignancy, often diagnosed at an advanced stage with poor prognosis. This review discusses current treatment strategies,...
0
1
2
#ASTRO24 A post-hoc unplanned pooled Analysis of COU-AA-302 and ACIS Trials exploring the impact of prior local therapy on Tx response and OS of men with mCRPC was presented by @Omar__Azem The key takeaways of this presentation were: 🚩1,132 received prior LT (RP/ RT), 22% had
0
4
5
Impact of prior local therapy on treatment response and survival of men with #mCRPC: a pooled analysis of COU-AA-302 and #ACIS trials. Presentation by @Omar__Azem @RushRadOnc. #ASTRO24 written coverage by @chavarriagaj @UofT > https://t.co/uoQBgne5sY
@ASTRO_org
0
7
9
The survival outcomes linked to ARPIs are not significantly compromised due to prior local therapy among patients with #mCRPC, according to late-breaking data presented by @Omar__Azem of @RushRadOnc today. Read more: https://t.co/B2jqkO4CKL
#ASTRO24 #ASTRO #RadOnc
urologytimes.com
A late-breaking abstract at ASTRO 2024 shows local therapy history does not significantly affect the risk of death in patients with mCRPC receiving an ARPI.
0
3
4
@Omar__Azem, PGY4 @RushRadOnc, kicking off #ASTRO24 with a prostate quick pitch "Impact of Prior Local Therapy (LT) on Treatment Response and Survival of Men with Metastatic Castrate Resistant Prostate Cancer (mCRPC): A Pooled Analysis of COU-AA-302 and ACIS Trials"
0
5
17
If a mucosal melanoma ever sneaks onto your patient list, we’ve got you covered🫡 Check out our review on Radiation Therapy in the Management of HNMM https://t.co/WnUqZfeV3I
#mdpicancers via @Cancers_MDPI @DrNikhilJoshiMD @MikeJelinekMD
mdpi.com
Mucosal melanoma of the head and neck (HNMM) is a rare but highly aggressive malignancy, often diagnosed at an advanced stage with poor prognosis. This review discusses current treatment strategies,...
0
1
2
Thanks to #radonc mentor extraordinaire Dr. Charles Thomas from @DHMC_RadOnc for spending the day with us @RushRadOnc as a visiting professor. So many words of wisdom about management of thymic malignancies, mentorship, & leadership. "Onwards!" @RushMedical @RushCancer
0
3
16
Demo Day! Our brachytherapy specialist, @S_Dooley7, guiding us through various intra-operative techniques. Great session, thanks Dr. Dooley! @RushCancer @d_golden
0
3
18
1
5
20
@SouMyajiT_RO @ASTRO_org @CGualano @RushRadOnc @RushUniversity @ARRO_org @VidalRadOnc @LeCompteMD @DrNikhilJoshiMD @GauravMarwahaMD @CGualano is the secret sauce to the @RushRadOnc residency program
0
1
5
Birthday lunch celebrating @Omar__Azem! Happy Birthday, Omar!Rush #RadOnc wouldn’t be the same without you! 🥳 @KatieScharf @RyanRauchMD @CGualano
0
1
14
Congrats to our @RushRadOnc and @RushRad grads! A beautiful night celebrating @ImKevinKing @MichaelZhouMD @rjspanthi and a remarkable year at @Rush_GME @RushMedical @RushCancer. Special thanks to @CGualano for the precision planning 👌🏽#bestnightoftheyear #radonc #graduation
2
5
34
Last evening we celebrated @ImKevinKing and @MichaelZhouMD’s graduation @RushRadOnc @RushCancer. An irreplaceable duo! We miss you and are excited for your futures!
0
2
19
Proud to share all of our continuing residents are presenting an oral or a poster at #ASTRO2023! 💪 @AdriannaECueto @Omar__Azem @SouMyajiT_RO @dsouzl @RushCancer @GauravMarwahaMD
0
3
6
Honored to be chosen to give an oral presentation @ASTRO_org . Thank you for all your support @SouMyajiT_RO. @KenTatebe @RushRadOnc @GauravMarwahaMD @DrNikhilJoshiMD #ASTRO2023 #BCSM #machinelesrning
1
2
13
Mock orals were a huge success and the afternoon debrief was amazing! 💯🎉 Great oral board prep for our residents and junior faculty! 🙌 Thank you to our awesome attendings! @RushMedical @RushCancer @GauravMarwahaMD @DrNikhilJoshiMD @dianwang84 @TKimMD @KenTatebe #radonc
0
7
26
#InService done...Now fun time with our program administrator @CGualano @RushRadOnc @dsouzl @ImKevinKing @Omar__Azem @MichaelZhouMD
0
1
13